 Home > Biochemistry News > Biotechnology News > "First-in-class" JAK inhibitors obtained FDA priority review qualification

"First-in-class" JAK inhibitors obtained FDA priority review qualification

 Last Update: 2021-04-29
 Source: Internet
 Author: User

Tags

treatment eye floaters

pku treatment

lime water treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Incyte announced today that the U.

GVHD is a potentially fatal complication that may occur after allogeneic stem cell transplantation.

Rucotinib is an oral "first-in-class" JAK1/JAK2 inhibitor.

This application is based on the results of the Phase 3 clinical trial REACH3 in patients with steroid refractory chronic GVHD.

In addition, rucotinib has reached a number of key secondary endpoints of the trial, including the median failure-free survival of rucotinib at week 24, which is significantly longer than the best existing treatment.

"Chronic GVHD is a life-threatening complication after stem cell transplantation, which brings a burden to the fragile patient population, which now has limited treatment options," said Dr.

Note: This article is intended to introduce medical and health research, not to recommend treatment options.

Reference materials:

[1] Incyte Announces Acceptance and Priority Review of sNDA for Jakafi® (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.